FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers“SILVER SPRING, Md., Dec. 19, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is announcing a final rule to update the definition of the nutrient content claim...
Orange County’s Needle Exchange Program is Finished“After Santa Ana officials battled a needle exchange program from setting up shop within city limits again, the local substance abuse clinic has rescinded its application to operate in Orange County – ending a saga...
Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC“Key Takeaways: Pembrolizumab plus chemotherapy significantly improved 4-year OS and EFS in resectable early-stage NSCLC compared to chemotherapy alone. The pembrolizumab regimen showed a...
CDC and SAMHSA Leaders Encourage HIV and Viral Hepatitis Testing in Substance Use Disorder Treatment“In a new joint letter, the leaders of the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA)...
FDA Grants Taletrectinib Priority Review for Advanced ROS1+ NSCLC“The FDA has granted priority review to a new drug application for taletrectinib, an investigational next-generation ROS1 TKI, for the treatment of patients with advanced ROS1-positive non–small cell...
More News and Updates